z-logo
Premium
Dietary Black Raspberry Seed Oil Ameliorates Inflammatory Activities in db/db Mice
Author(s) -
Lee Hee Jae,
Jung Hana,
Cho Hyunnho,
Lee Kiuk,
Kwak HoKyung,
Hwang Keum Taek
Publication year - 2016
Publication title -
lipids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 120
eISSN - 1558-9307
pISSN - 0024-4201
DOI - 10.1007/s11745-016-4159-4
Subject(s) - adipose tissue , chemistry , leptin , endocrinology , medicine , biology , biochemistry , obesity
Abstract The objective of this study was to evaluate the status of the markers related to inflammation in db/db mice fed black raspberry seed (BRS) oil, which is rich in α‐linolenic acid. Mice were divided into four groups: (1) C57BL/6 mice fed 16 % calories from soybean oil (normal CON); (2) C57BL/KsJ‐ db/db mice fed 16 % calories from soybean oil (CON); (3) C57BL/KsJ‐ db/db mice fed 8 % calories from soybean and 8 % calories from BRS oil (BRS 50 %); and (4) C57BL/KsJ‐ db/db mice fed 16 % calories from BRS oil (BRS 100 %). After 10 weeks, n‐6/n‐3 fatty acid ratios were significantly ( P < 0.05) lower in the livers and epididymal adipose tissues of the BRS 50 % and BRS 100 % mice than in the CON. Serum TNFα and IL‐6 were significantly ( P < 0.05) lower in the BRS 50 % and BRS 100 % than in the CON. Serum IL‐10 was significantly ( P < 0.05) higher in the BRS 100 % than the CON. In the liver and epididymal adipose tissue, mRNA levels of pro‐inflammatory markers in the BRS 50 % and BRS 100 % were lower than in the CON. Anti‐inflammatory markers were higher in the epididymal adipose tissues of the BRS 50 % and BRS 100 % than in the CON. In the epididymal adipose tissue, macrophage infiltration markers (F4/80 and CD68) and leptin mRNA were significantly ( P < 0.05) lower in the BRS 50 % and BRS 100 % than in the CON. Results of this study suggest that BRS oil may have anti‐inflammatory effects in obese diabetic mice by ameliorating inflammatory responses.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here